Our previous studies in mice suggest that chronic inhibition of mPGES-1 is less likely than NSAIDs to cause thrombosis (e.g., myocardial infarction)5, and reduces restenosis after vascular injury, due to the increased biosynthesis of PGI2. Here, PTGES is linked to myocardial infarction.